{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:09:12Z","timestamp":1786784952217,"version":"build-2736575974"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2005,7,1]],"date-time":"2005-07-01T00:00:00Z","timestamp":1120176000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,12]],"date-time":"2022-09-12T00:00:00Z","timestamp":1662940800000},"content-version":"vor","delay-in-days":6282,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2005,7]]},"DOI":"10.1016\/j.fertnstert.2004.12.058","type":"journal-article","created":{"date-parts":[[2005,7,10]],"date-time":"2005-07-10T09:17:35Z","timestamp":1120987055000},"page":"154-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women"],"prefix":"10.1016","volume":"84","author":[{"given":"Stefano","family":"Palomba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Francesco","family":"Orio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Falbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achille","family":"Tolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Cimini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2004.12.058_bib1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib2","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(00)03622-9","article-title":"Uterine fibroids","volume":"357","author":"Steward","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib3","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1098-2744(199611)17:3<151::AID-MC7>3.0.CO;2-I","article-title":"Inhibition of estrogen stimulated growth of uterine leiomyomas by selective estrogen receptor modulators","volume":"17","author":"Fuchs-Young","year":"1996","journal-title":"Mol Carcinog"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01771666","article-title":"A pharmacological review of raloxifene","volume":"14","author":"Bryant","year":"1996","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib5","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1172\/JCI116985","article-title":"Raloxifene (LY139481 HCL) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats","volume":"93","author":"Black","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib6","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0002-9378(98)70148-6","article-title":"Effects of raloxifene in a guinea pig model for leiomyomas","volume":"179","author":"Porter","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/107155760000700410","article-title":"Preclinical evidence for therapeutic efficacy of selective estrogen receptor modulators for uterine leiomyoma","volume":"7","author":"Walker","year":"2000","journal-title":"J Soc Gynecol Investig"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0015-0282(01)01849-0","article-title":"Effects of raloxifene treatment on uterine leiomyomas in postmenopausal women","volume":"76","author":"Palomba","year":"2001","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib9","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1093\/humrep\/17.12.3213","article-title":"Effectiveness of combined GnRH analogue plus raloxifene administration in the treatment of uterine leiomyomas","volume":"17","author":"Palomba","year":"2002","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib10","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1093\/humrep\/deh296","article-title":"Long-term effectiveness and safety of GnRH agonist plus raloxifene administration in women with uterine leiomyomas","volume":"19","author":"Palomba","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib11","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1095\/biolreprod63.5.1322","article-title":"Altered hormonal responsiveness of proliferation and apoptosis during myometrial maturation and the development of uterine leiomyomas in the rat","volume":"63","author":"Burroughs","year":"2000","journal-title":"Biol Reprod"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib12","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1055\/s-2004-828615","article-title":"Apoptosis in human uterine leiomyomas","volume":"22","author":"Martel","year":"2004","journal-title":"Semin Reprod Med"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib13","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/humupd\/dmh019","article-title":"Sex steroidal regulation of uterine leiomyoma growth and apoptosis","volume":"10","author":"Maruo","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib14","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0167-4781(98)00204-8","article-title":"PCNA, a multifunctional ring on DNA","volume":"1443","author":"Tsurimoto","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib15","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S0079-6603(04)78006-X","article-title":"The PCNA-RFC families of DNA clamps and clamp loaders","volume":"78","author":"Majka","year":"2004","journal-title":"Prog Nucleic Acid Res Mol Biol"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib16","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.bbamcr.2003.08.012","article-title":"Structural biology of the Bcl-2 family of proteins","volume":"1644","author":"Petros","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.bbamcr.2003.08.010","article-title":"Bcl-2 family members and disease","volume":"1644","author":"Sorenson","year":"2004","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib18","doi-asserted-by":"crossref","first-page":"8590","DOI":"10.1038\/sj.onc.1207102","article-title":"The Bcl-2 family","volume":"22","author":"Cory","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib19","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0002-9378(98)70635-0","article-title":"A prospective randomized study to evaluate leuprolide acetate treatment before laparoscopic myomectomy","volume":"178","author":"Zullo","year":"1998","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib20","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0960-0760(01)00177-7","article-title":"Expression of Bcl-2, Bcl-x, Mcl-1, Bax and Bak in human uterine leiomyomas and myometrium during the menstrual cycle and after menopause","volume":"80","author":"Wu","year":"2002","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib21","doi-asserted-by":"crossref","first-page":"5593","DOI":"10.1210\/jcem.86.11.8008","article-title":"Up-regulation by IGF-I of proliferating cell nuclear antigen and Bcl-2 protein expression in human uterine leiomyoma cells","volume":"86","author":"Gao","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib22","first-page":"293","article-title":"Increased expression of Bcl-2 protein in human uterine leiomyoma and its up-regulation by progesterone","volume":"82","author":"Matsuo","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib23","first-page":"3303","article-title":"Raloxifene administration in premenopausal women with uterine leiomyomas","volume":"87","author":"Palomba","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.fertnstert.2003.06.009","article-title":"Raloxifene prevents the growth of uterine leiomyomas in premenopausal women","volume":"81","author":"Jirecek","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib25","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/j.fertnstert.2004.03.009","article-title":"Does raloxifene inhibit the growth of uterine fibroids?","volume":"81","author":"Palomba","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.7863\/jum.1998.17.11.699","article-title":"Use of transvaginal ultrasonography to monitor the effects of tamoxifen on uterine leiomyoma size and ovarian cyst formation","volume":"17","author":"Schwartz","year":"1998","journal-title":"J Ultrasound Med"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib27","first-page":"625","article-title":"Tamoxifen associated uterine pathology in breast cancer patients with abnormal bleeding","volume":"18","author":"Fotiou","year":"1998","journal-title":"Anticancer Res"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib28","first-page":"1876","article-title":"Estrogen receptor gene expression in human uterine leiomyomata","volume":"80","author":"Brandon","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2004.12.058_bib29","first-page":"1112","article-title":"Estrogen receptors (ERalpha\/ERbeta) in normal and pathological growth of the human myometrium","volume":"276","author":"Benassayag","year":"1999","journal-title":"Am J Physiol"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205005972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028205005972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:09:27Z","timestamp":1758006567000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028205005972"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,7]]}},"alternative-id":["S0015028205005972"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.12.058","relation":{},"ISSN":["0015-0282"],"issn-type":[{"value":"0015-0282","type":"print"}],"subject":[],"published":{"date-parts":[[2005,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antiproliferative and proapoptotic effects of raloxifene on uterine leiomyomas in postmenopausal women","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2004.12.058","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}